Characterization of adverse cutaneous effects in the setting of enfortumab vedotin for metastatic urothelial carcinoma: A retrospective review

被引：3

作者：

Malik, Rhea ^{[1
,2
]}

Xiang, David H. ^{[1
,2
]}

Riew, Grant J. ^{[1
,2
]}

Sanchez-Melendez, Stephanie ^{[2
,3
]}

Afvari, Shawn ^{[2
,4
]}

Leboeuf, Nicole R. ^{[2
,5
]}

Nambudiri, Vinod E. ^{[2
,5
]}

机构：

[1] Harvard Med Sch, Boston, MA USA

[2] Brighamand Womens Hosp, Dept Dermatol, 221 Longwood Ave, Boston, MA 02115 USA

[3] Ponce Hlth Sci Univ, Sch Med, Ponce, PR USA

[4] New York Med Coll, Valhalla, NY USA

[5] Dana Farber Canc Inst, Dept Cutaneous Oncol, Boston, MA USA

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2024年 / 91卷 / 04期

关键词：

adnexal tumor; cutaneous effects; enfortumab vedotin; S[!text type='JS']JS[!/text; TEN; urothelial cancer;

D O I：

10.1016/j.jaad.2024.06.037

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

[No abstract available]

引用

页码：753 / 755

页数：3

共 3 条

[1]

Dobry Allison S, 2021, JAAD Case Rep, V14, P7, DOI 10.1016/j.jdcr.2021.05.020

[2] Flexural Exanthema From Enfortumab Vedotin [J].

Keerty, Dinesh ;

Graham, Laura ;

Haynes, Elizabeth ;

Hembree, Timothy N. .

CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (05)

[3] Pivotal Trial of Enfortumab Vedotin in Urothelial Carcinoma After Platinum and Anti-Programmed Death 1/Programmed Death Ligand 1 Therapy [J].

Rosenberg, Jonathan E. ;

O'Donnell, Peter H. ;

Balar, Arjun, V ;

McGregor, Bradley A. ;

Heath, Elisabeth, I ;

Yu, Evan Y. ;

Galsky, Matthew D. ;

Hahn, Noah M. ;

Gartner, Elaina M. ;

Pinelli, Juan M. ;

Liang, Shang-Ying ;

Melhem-Bertrandt, Amal ;

Petrylak, Daniel P. .

JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (29) :2592-+

← 1 →